Evaluation of the safety, recovery, half-life, and clinical efficacy of antithrombin III (human) in patients with hereditary antithrombin III deficiency. Cooperative Study Group.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples